Time filter

Source Type

Many health-promoting benefits have been associated with the intake of the omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). As a dietary supplement, Superba™ krill oil provides these important fatty acids to a large part in the form of phospholipids. Due to the special combination of omega-3 phospholipids and the antioxidant astaxanthin, krill oil has been alleviated with numerous positive health effects. The intention of this article is to provide information on the influence of the structural form of omega-3 fatty acids (phospholipids from krill oil versus triglycerides from fish oil) on blood plasma levels of EPA and DHA. Two human clinical studies suggest that omega-3s provided in phospholipid form accumulate in higher amounts in plasma than when taken up in triglyceride form. Source

Aker Biomarine Antarctic As | Date: 2013-03-11

The present invention provides a chewable oral delivery vehicle comprising a chewable matrix and at least one soft gelatin capsule encapsulating an oxidizable fatty acid composition, wherein the at least one soft gelatin capsule is incorporated into the chewable matrix. The chewable matrix may be a gummy candy or jelly sweet. The oxidizable fatty acid composition may be a free fatty acid composition, fatty acid ester composition, glyceride composition, phospholipid composition or combinations thereof, and preferably comprise one or more fatty acids or residues thereof selected from the group consisting of eicosapentaenoic-, docosahexaenoic-, docosapentaenoic-, conjugated linoleic-, palmitoleic-, trans palmitoleic-, alpha linolenic-, gamma linolenic-, and stearidonic acid and combinations thereof.

Aker Biomarine Antarctic As | Date: 2015-02-12

This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO

Aker BioMarine Antarctic AS | Date: 2015-06-02

The present invention provides methods for improving flesh quality in farmed fish, and in particular decreasing gaping in fillets from farmed fish as well as increasing flesh and fillet firmness.

This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.

Discover hidden collaborations